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Human embryonic stem cells (hESCs) are self-renewing pluripotent cells with relevance to
treatment of numerous medical conditions. However, a global understanding of the role of the
hESC proteome in maintaining pluripotency or triggering differentiation is still largely lacking.
The emergence of top-down proteomics has facilitated the identification and characterization
of intact protein forms that are not readily apparent in bottom-up studies. Combined with
metabolic labeling techniques such as stable isotope labeling by amino acids in cell culture
(SILAC), quantitative comparison of intact protein expression under differing experimental
conditions is possible. Herein, quantitative top-down proteomics of hESCs is demonstrated
using the SILAC method and nano-flow reverse phase chromatography directly coupled to a
linear-ion-trap Fourier transform ion cyclotron resonance mass spectrometer (nLC-LTQ-FT-
ICR-MS). In this study, which to the best of our knowledge represents the first top-down
analysis of hESCs, we have confidently identified 11 proteins by accurate intact mass, MS/MS,
and amino acid counting facilitated by SILAC labeling. Although quantification is challenging
due to the incorporation of multiple labeled amino acids (i.e., lysine and arginine) and arginine
to proline conversion, we are able to quantitatively account for these phenomena using a
mathematical model. (J Am Soc Mass Spectrom 2010, 21, 879–889) © 2010 Published by
Elsevier Inc. on behalf of American Society for Mass SpectrometryHuman embryonic stem cells (hESCs) are pluri-potent cells derived from the inner cell mass ofblastocyst stage embryos that possess the abil-
ity to self-renew or differentiate into almost any human
cell type. This makes hESCs a potentially valuable tool
for regenerative medicine, where tissues damaged by
disease or injury can be restored via hESC-derived cells.
The ability of hESCs to be maintained in cell culture
allows the opportunity for investigation into how these
cells maintain pluripotency and how they progress
through differentiation to various cell types [1]. Explor-
ing the proteome of hESCs and how it changes qualita-
tively and quantitatively is an integral part of under-
standing the overall biology of this cell type, and will
yield invaluable information toward the development
of new medical treatments.
Top-down proteomics has emerged as a powerful
technique for protein analysis and is a growing area of
research in the mass spectrometry community. The
typical experimental strategy for top-down proteomic
analysis includes the front-end separation of intact
proteins, their detection and fragmentation in a mass
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doi:10.1016/j.jasms.2010.01.031spectrometer, and subsequent identification based on
sequence information obtained from their resulting MS
and MS/MS spectra [2, 3]. Intact proteins present a
wide range of physical and chemical properties that
challenge front-end separation techniques [4–6], mass
analyzer duty cycle [7], and protein identification algo-
rithms. These challenges hinder high throughput anal-
yses and, thus, the top-down approach has lagged the
more commonly employed bottom-up approach. How-
ever, the emergence and development of new separa-
tions technologies such as GELFREE separation [8–11],
high resolving power hybrid mass analyzers such as the
LTQ-FT-ICR [12], and LTQ-Orbitrap [13, 14], and bioin-
formatics software such as ProSightPC [15] have greatly
improved the capability for addressing the challenges
posed by top-down proteomics. Recently, the top-down
approach has been utilized by Kelleher and coworkers
to examine multiple modifications of human histones,
including methylation and acetylation [16]. The Kelle-
her group also has applied GELFREE technology to
address front end separation challenges in the top-
down analysis of the low mass proteome of HeLa cell
extracts [17]. Top-down proteomics has also been used
to identify single amino acid polymorphisms and char-
acterize post-translational proteolysis and phosphory-
lation of affinity purified rat cardiac troponin [18].
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allowed investigators to take advantage of the top-
down approach’s ability to identify and characterize
multiple post-translational modifications (PTMs) and
identify genetic modifications while utilizing bottom-up
proteomics to achieve higher throughput [19].
Quantitative top-down proteomics most often uti-
lizes stable isotope labeling to create an internal stan-
dard from which reliable quantitative data may be
obtained. Gordon et al. demonstrated with bovine and
equine cytochrome c that even small differences-in this
case, three amino acids between a protein and a struc-
tural homologue from a different species are enough to
produce different charge state distributions that hinder
quantification unless the signal from all charge states is
taken into account [20]. Deuterated leucine has been
incorporated into model cell cultures, including E. coli
and S. cerevisiae [21, 22], which facilitated identification
of proteins using accurate intact mass and amino acid
counting; however, quantification with deuterated la-
bels using reversed-phase chromatography is problem-
atic because elution times decrease for the deuterated
analytes [23, 24]. 15N/14N metabolic labeling has been
successfully utilized the yeast proteome and, moreover,
was employed on a chromatographic time scale to
identify 22 intact proteins from S. cerevisiae [25]. Stable
isotope labeling by amino acids in cell culture (SILAC)
was introduced by Mann and coworkers as another
means of quantifying peptides and proteins, whereby
stable isotope labeled amino acids are supplemented to
cull culture growth media to produce co-eluting labeled
and unlabeled protein or peptide analytes. This tech-
nique is widely implemented in bottom-up experiments
using labeled arginine and lysine residues in conjunc-
tion with trypsin proteolysis [26, 27].
Quantification of intact proteins using SILAC has
been computationally modeled and demonstrated in
affinity purified proteins expressed with an E. coli
vector and 99% stable isotope incorporation of a single
label was achieved [28]. We have previously described
the implementation of SILAC on a chromatographic
time scale for protein identification and quantification
using 13C6-arginine supplemented with the growth me-
dia of the filamentous fungus Aspergillus flavus, and also
demonstrated that incomplete label incorporation in a
prototrophic organism results in broad protein isotopic
distributions that hinders the use of SILAC labeled
intact proteins for relative quantification or assistance in
identification. A mathematical relationship was also
described, which characterizes the relationship of label
incorporation with the observed experimental protein
signal [29].
Mass spectrometry based proteomics is becoming
increasingly employed for the analysis of various stem
cell populations at increasing depth and detail [30].
Recently, mass spectrometry, electron capture, and
electron-transfer dissociation (ECD and ETD, respec-
tively) were used to characterize the phosphoproteome
of hESCs [31, 32] and label free quantification has beencarried out to characterize 74 different PTM combina-
tions of histone H4 in hESCs [33]. The iTRAQ method
has been used to track the change in mouse embryonic
stem cell protein expression during differentiation [34].
Bottom-up quantification using SILAC has been uti-
lized to identify and quantify over 5000 mouse embry-
onic stem cell proteins [35], and has been recently
demonstrated with hESCs to seek out differentially
expressed cell surface markers between pluripotent and
differentiating cell populations [36].
This study represents our initial efforts to establish
top-down analysis of SILAC labeled human embryonic
stem cells, in which we utilize top-down proteomics to
analyze human embryonic stem cells that have been
dual labeled with 13C6-arginine (Arg6) and
13C6,
15N2-
lysine (Lys8) with approximately greater than 98% label
incorporation as verified by bottom-up proteomics. We
detected 62 intact protein precursors from which we
were able to unambiguously identify 11 based on
accurate intact mass, MS/MS fragmentation data,
and amino acid counting. Furthermore, we character-
ize the effect of multiple stable isotope labels, minute
incorporation of unlabeled amino acids, and arginine-
proline conversion on the labeled protein’s isotopic
distribution.
Experimental
Culture and SILAC Labeling of hESCs
H9 cells were maintained on mouse embryonic fibro-
blast (MEF) conditioned medium (CM) according to a
protocol adapted from Xu et al. [37]. Briefly, MEF cells
were inactivated by mitomycin c (Sigma Aldrich, St.
Louis, MO, USA) treatment and plated at 55,000/cm2.
HESC medium consisting of DMEM/F12 (Invitrogen,
Carlsbad, CA, USA), 20% knockout serum replacement
(Invitrogen), 1 mM L-glutamine (Invitrogen), 0.1 mM
-mercaptoethanol, 1% nonessential amino acids (In-
vitrogen), and 4 ng/mL basic fibroblast growth factor
(bFGF; Sigma Aldrich) was conditioned for 24 h on
MEF cells. CM was collected for 7 d, pooled, and
supplemented with 4 ng/mL bFGF (Sigma Aldrich).
CM for SILAC labeling of hESCs was prepared using
protocols previously described [38]. Briefly, SILAC me-
dium consisting of DMEM/F12 without L-lysine and
L-arginine (Pierce, Rockford, IL, USA), 13C6 L-arginine
(Pierce), 13C6
15N2 L-Lysine (Pierce), 20% knockout
serum replacement (Invitrogen), 1 mM L-Glutamine
(Invitrogen), 0.1 mM -mercaptoethanol, 1% nonessen-
tial amino acids (Invitrogen), and 4 ng/mL basic fibro-
blast growth factor (bFGF, Sigma Aldrich) was condi-
tioned for 24 h on MEF cells. CM was collected for
7 d, pooled, and supplemented with 4 ng/mL bFGF
(Sigma Aldrich). It is important to note that the
knockout serum replacement does not contain lysine
or arginine [39].
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Confluent H9 cells were lysed with 8M Urea (Sigma
Aldrich) and 50 mM ammonium bicarbonate (Fisher
Scientific, Hampton, NH, USA) and frozen at 80 °C.
Before analysis by LC-MS, cell lysates were concen-
trated and desalted on 5 m, C8 stationary phase beads
(Michrom Bioresources, Auburn, CA, USA) according
to a protocol adapted from Winston and Fitzgerald [40]
in which 5 mg of stationary phase beads in 400 L of
methanol was added to 75 L of intact protein SILAC
mixture in a 1.5 mL microcentrifuge tube and vortexed
for 5 min, followed by 3 min centrifugation at 10,000 
g. After rinsing the sides of the tube twice with 20 L of
methanol, the sample was centrifuged again for 3 min
at 10,000  g. After discarding the supernatant, the
protein-stationary phase pellet was washed with 1 mL
of 0.1% trifluoroacetic acid (Sigma Aldrich), vortexed
for 1 min, and then centrifuged for 3 min at 10,000  g.
The steps were repeated two more times before recon-
stituting sample in 100 mM ammonium bicarbonate pH
7.8 and filtering through a 50 kDa Microcon molecular
weight cutoff filter (Millipore, Billerica, MA, USA) to
remove stationary phase beads from solution.
Bottom-up sample preparation. Fifty g of Arg6, Lys8-
labeled protein from human embryonic stem cells
was combined with 2 Laemmli buffer containing
-mercaptoethanol, boiled 5 min, and cooled on ice. The
sample was loaded and ran on a Criterion 10%–20%
Tris-HCl gel (BioRad, Hercules, CA, USA) at 200 V and
visualized with BioSafe Coomassie stain. The gel lane
was divided into eight equal fractions, each of which
was reduced with DTT, alkylated with iodoacetamide,
and digested with trypsin according to a protocol
adapted from Shevchenko et al. [41] First, excised gel
bands were incubated for 30 min at room temperature
in a 1:1 mixture of acetonitrile:100 mM ammonium
bicarbonate pH 7.8. After removing the solution to
waste, the gel pieces were dehydrated with 100% ace-
tonitrile. Gel pieces were reduced for 30 min at 56 °C in
10 mM dithiothreitol (Sigma Aldrich) in 100 mM am-
monium bicarbonate pH 7.8, followed by dehydration
with 100% acetonitrile. Free thiols from the reduced
cys–cys disulfide bonds were alkylated with 55 mM
iodoacetamide (Sigma Aldrich) in 100 mM ammonium
bicarbonate and incubated in the dark at room temper-
ature. After dehydration with acetonitrile, samples
were digested for 18 h at 37 °C with 20 ng/L proteom-
ics grade trypsin (Sigma Aldrich) in 36 mM ammonium
bicarbonate, 0.1 mM HCl, and 9% acetonitrile. The
digestion was halted with the addition of a 1:2 mixture
of 5% formic acid:acetonitrile followed by incubation
for 15 min at 37 °C, after which the solution containing
the tryptic peptides was removed and saved. The gel
pieces were dehydrated with acetonitrile, and the re-
sulting solution was removed and pulled with the other
samples, which were reduced to dryness in a SpeedVac(ThermoFisher, San Jose, CA, USA) and frozen at
80 °C until needed.
Top-down LC-MS/MS. All LC solvents were purchased
from Burdick and Jackson (Muskegon, MI, USA). Re-
versed-phase nano-flow liquid chromatography was
performed on a nanoLC-2D system (Eksigent, Dublin,
CA, USA) utilizing a vented column configuration [42].
Ten L samples containing 1 g of total protein were
injected using the autosampler, desalted on a 75 m 
50 mm IntegraFrit (New Objective, Woburn, MA, USA)
trap packed in-house with mRP-C18 5 m stationary
phase and eluted onto a PicoFrit capillary column with
a 15 m emitter tip (New Objective) also packed in-
house with mRP-C18 stationary phase (Agilent, Palo
Alto, CA, USA). The final packed volume of the column
had dimensions 75 m i.d. 200 mm and was enclosed
in a modified Hot-Pocket column heater (ThermoFisher)
operating at 80 °C. Mobile phases A and B consisted of
98% water, 2% acetonitrile, and 2% water, 98% acetoni-
trile, respectively, with both containing 0.2% (vol/vol)
formic acid as an ion-pairing reagent. Samples were
injected and desalted on the trap at 1.5 L/min with 2%
mobile phase B for a metered injection of 30 L. After
desalting, a 10-port valve (VICI, Houston, TX, USA)
switched the trap in line with a nano-flow gradient at
300 nL/min, at which time data collection also com-
menced. The gradient held at 2% mobile phase B for 10
min, ramped to 25% over 5 min, then to 65% B over the
following 70 min. The gradient was then ramped to 95%
B in 5 min and held for 10 min before re-equilibrating at
2% B for 10 min.
Mass spectrometric analyses were performed on a 7T
LTQ-FT Ultra (ThermoFisher) with a pulse sequence
consisting of four events, providing for a broadband
acquisition in profile mode followed by three data-
dependent MS/MS experiments. All mass measure-
ments were performed inside the ICR cell. All events
used 1 microscan to determine ionization time to reach
the target AGC limit of 1  106. The resolving power of
all four events was set at 100,000FWHM at m/z  400.
MS/MS settings used an isolation width of 7 m/z and a
normalized collision energy of 18% for 30 ms. CID was
performed on the three most abundant m/z values from
the precursor ion scan in the LTQ followed by product
ion detection in the ICR cell. Precursor ions with 1,
2, and 3 charges were excluded from MS/MS.
Precursors isolated for MS/MS were dynamically ex-
cluded for 45 s after three repeat analyses within a 30 s
window to reduce redundant analysis of abundant
precursor ions that may dominate the mass spectra for
long periods of time.
Top-down data analysis. RAW LC-MS data files were
imported into ProSightPC 2.0 (ThermoFisher) using a
THRASH [5] algorithm to determine the monoisotopic
peak of analyte signals with a S/N ratio of 3:1 or
greater. Intact precursor and fragment ion masses were
searched against the IPI human database (ver. 3.63)
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absolute mass search, followed by a biomarker search
for all data that did not yield an ID with E value less
than 1E4 in the absolute mass search. Intact protein
precursor and fragment ion data were searched initially
with ion mass tolerances set at 10 ppm. An additional
search was performed with fragment tolerances of 1
Da to accommodate sample handling modifications to
the mass (e.g., deamidation) or error in monoisotopic
peak picking by the THRASH algorithm. Identified
protein sequences reported from the searches were
confirmed using arginine and lysine counting from the
precursor ion spectra. Analysis of SILAC labeled pro-
tein distributions and theoretical distributions with
varying arginine and lysine labeling efficiencies in
addition to different amounts of proline conversion was
carried out using ICR-2LS (PNNL, Richland, WA, USA)
and Microsoft Excel (Redmond, WA, USA).
Bottom-up LC-MS/MS. In-gel digested peptide sam-
ples were separated using the same LC system, column
configuration and mobile phases described vide supra.
The stationary phase employed was Magic C18AQ (5
m particle, 200 Å pore size) (Microm BioResources,
Auburn, CA, USA). Ten L of sample was injected and
desalted at 1.5 L/min on the trap before switching in
line with the gradient at a flow rate of 300 nL/min. The
gradient held at 2% B for 5 min before ramping to 10%
B over 2 min, followed by an increase to 50% B over the
next 60 min. The gradient then ramped to 95% B in 3
min, held for 5 min, then re-equilibrated at 2% B for 10
min.
Peptides were detected on the LTQ-FT Ultra with a
pulse sequence containing four scan events. A broad-
band scan was performed in the ICR cell followed by
three data-dependent MS/MS events in the ion trap at
an isolation width of 2 m/z and normalized collision
energy of 30% for 30 ms; 1 charge states were rejected
from MS/MS and dynamic exclusion was employed for
45 s after 2 repeat analyses in a 30 s window.
Bottom-up data analysis. RAW LC-MS files were pro-
cessed using MASCOT Distiller (Matrix Science, Bos-
ton, MA, USA) to create peak lists in .mgf format to
be searched against the IPI human database using
MASCOT (Matrix Science, London, UK) [43]. Searches
employed a peptide mass tolerance of 5 ppm and a
fragment ion tolerance of 1 Da. Fixed modification
included carboxyamidomethylation of cysteine, with
variable modifications including methionine oxida-
tion and deamidation of asparagines and glutamine
residues.
Results and Discussion
H9 cells cultured in CM and SILAC CM for at least five
passages were lysed, combined at a 1:1 ratio as deter-
mined by Bradford assay, and subjected to an initial
sample cleaning procedure with C8 reversed-phasecolumn packing material. The resulting SILAC mixture
was analyzed by nano-flow LC-MS/MS as described
vide supra. Figure 1 shows examples of two proteins
identified by top-down LC-MS/MS. Figure 1a demon-
strates the detection of an 8.5 kDa SILAC pair with
charge states ranging from 6 to 12. The light form of
the 7 charge state was isolated for collision induced
dissociation, allowing the protein to be identified as
ubiquitin c splice variant using the biomarker search
method in ProSightPC. The sequence of the protein,
identified with an E value of 2.94E-19, was then used to
calculate a mass difference between the light and heavy
protein forms of 80.1798 Da based on the presence of
four arginine residues and seven lysine residues. This
mass difference translates to an m/z difference of
11.4542 at z 7, which strongly correlates with the mass
difference between the SILAC pair in the experimental
precursor spectrum. This increases the confidence of the
protein identification.
Likewise, the principle of making an initial identifi-
cation from MS and MS/MS data and confirming with
mass difference of the SILAC pair is also illustrated in
Figure 1b. Here, SILAC pairs of a 12.3 kDa protein with
charge states ranging from 9 to 13 are detected, with
the light form of the 12 charge state being isolated for
MS/MS analysis. Searching in absolute mass mode with
ProSightPC identified the protein as macrophage mi-
gration inhibitory factor with an E value of 3.02E-7.
Although the noisy broadband and MS/MS spectra, in
addition to only a few identified product ions, would
normally cast doubt on the confidence of the identifica-
tion, the calculated mass difference for five arginines
and three lysines of 54.1432 Da between the light and
heavy forms given by the predicted sequence again
matches the m/z difference of 4.5119 at z  12 of the
experimental precursor ion spectrum, giving additional
confidence to the identified sequence. We were simi-
larly able to identify 11 intact proteins from hESC lysate
(Table 1). For each protein, the mass difference between
the SILAC pair peaks was matched to the number of
labels in the identified sequence within a tolerance of 10
ppm. Seven of the 11 identified proteins were full intact
proteins identified by the absolute mass search in
ProSightPC, and four were identified by biomarker
search, meaning they are truncated forms of intact
protein sequences. Four of the proteins identified by
top-down analysis are variants of thymosin or prothy-
mosin, of which only one form was identified in a
parallel bottom-up study (data not shown). Five of the
11 proteins identified were acetylated at the N-terminus,
including histone H4. Interestingly, three of the pro-
teins identified in Table 1 returned multiple protein hits
with E values less than the cutoff value of E-4 when
searched and could not be unambiguously identified
using ProSight PC 2.0. These included the ubiquitin c
splice variant (five proteins), nucleophosmin 1 isoform
3 (four proteins), and hypothetical protein LOC140699
isoform 1 (six proteins), and are shown in Table 2 along
with other protein forms that met the cutoff value of
y fac
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pairs for each of the corresponding spectra and com-
paring with the number of arginine and lysine residues
in each case yielded unambiguous protein identifica-
tion. For example, nucleophosmin 1 isoform 3 contain-
ing 1 Arg and 3 Lys was identified with an E value of
Figure 1. Precursor and product ion mass sp
addition to their identified sequences and E-valu
variant and (b) macrophage migration inhibitor5.88E-9 in a biomarker search in ProSight PC in additionto three other proteins that met the cutoff value for
identification of 1E-4. These included neurofascin (E 
5.94E-5) containing 1 Arg and 1 Lys, ubiquitin carboxyl-
terminal hydrolase (E  1.16E-6) containing 1 Lys, and
DC30 (E  3.30E-6) containing 2 Arg. Analyzing the
mass difference between the light and heavy protein
of intact protein SILAC pairs are shown in
scored by ProSightPC for (a) ubiquitin c splice
tor.ectra
es assignal gave a M of 30.0627 Da, which correlates to one
88.3
884 COLLIER ET AL. J Am Soc Mass Spectrom 2010, 21, 879–889labeled arginine and three labeled lysine residues. Of
the four total protein sequences that met the E value
cutoff, only nucleophosmin contained labeled resi-
dues that matching the composition given by the M
of the experimental spectrum.
Although heavy and light pairs of SILAC-labeled
intact proteins were detected, the ratio of abundance of
light to heavy protein initially appeared to deviate from
the expected 1:1 ratio. A closer inspection of the isotopic
distributions of the heavy labeled proteins, illustrated
in the upper left panels of both Figure 1a and b, reveal
more complexity to the distribution than is present in
the light protein signal, with additional isotopic peaks
appearing at both lesser and greater m/z values than
expected. This complexity is a compounded effect of the
incorporation efficiency of the two different stable-
isotope labeled amino acids, in addition to contribution
Table 1. hESC proteins identified by top-down quantitative pro
Accession
number Protein description
Theoretical
mass (Da)
Obs
m
(
IPI00455510 Isoform 2 of prothymosin  11977.90 119
IPI00220828 Thymosin -4 4960.49 49
IPI00658013 Nucleophosmin 1 isoform 3 3096.51 30
IPI00180240 Thymosin -4-like protein 3 4970.51 49
IPI00329028 WD Repeat-containing
protein 5B
3864.04 38
IPI00793729 Ubiquitin C splice variant 8559.62 85
IPI00220827 Thymosin -10 4933.52 49
IPI00220362 10 kDa heat shock protein,
mitochondrial
10835.80 108
IPI00218635 Hypothetical protein
LOC140699 isoform 1
4528.44 45
IPI00293276 Macrophage migration
inhibitory factor
12337.20 123
IPI00453473 Histone H4 11388.40 113
Table 2. Intact protein identifications facilitated by amino acid l
Accession
number Protein description
Theoretical
mass (Da)
IPI00793729 Ubiquitin c splice variant 8559.62
IPI00793330 12 kDa protein 8559.62
IPI00186004 Ankyrin repeat domain 36B 8559.55
IPI00935575 Hypothetical protein
XP_002342919
8559.53
IPI00022557 Proteinase-activated receptor 4 8559.54
IPI00658013 Nucleophosmin 1 isoform 3 3096.51
IPI00470575 Neurofascin isoform 9 3096.54
IPI00184533 Ubiquitin carboxyl-terminal
hydrolase
3096.49
IPI00022947 DC30 3096.53
IPI00218635 Hypothetical protein
LOC140699 isoform 1
4528.44
IPI00885141 Isoform 3 of FAM149A 4528.47
IPI00011465 Thymic stromal cotransporter
homolog
4528.42
IPI00885173 Isoform 4 of FAM149A 4528.47
IPI00878107 Highly similar to interleukin 6 4528.48
IPI00027547 Dermcidin 4828.48 45from the metabolic conversion of heavy arginine to
heavy proline [38, 44]. However, the SILAC ratio calcu-
lated as the sum of light isotope abundances divided by
the heavy isotope abundances still results in a value of
unity. Specifically, the SILAC ratios calculated for ubiq-
uitin c splice variant and macrophage migration inhib-
itory factor were 1.05 and 0.90, respectively, both falling
within the range of variability of SILAC ratios observed
in bottom-up SILAC experiments with the same sam-
ples (data not shown).
In addition to the ability to confirm protein identifi-
cations with the M of the light and heavy forms of the
protein observed in the precursor ion spectra, the
incorporation of amino acid labels in MS/MS fragment
ions of the same protein can be confirmed in cases
where both the heavy and light forms of the protein are
selected for CID. Figure 2 shows an overlay of the
ic analysis
d Mass
diff.
(ppm)
No.
matching
fragments E value P score Search type
9 9.18 18 4.67E-24 1.17E-29 Absolute mass
6 6.80 35 1.84E-46 4.6E-52 Absolute mass
3 0.53 6 5.88E-09 3.58E-14 Biomarker
9 3.22 9 1.59E-9 3.97E-15 Absolute mass
4 0.88 8 6.31E-9 3.84E-14 Biomarker
2 0.43 14 2.94E-19 1.79E-24 Biomarker
2 1.01 29 4.15E-46 1.04E-51 Absolute mass
5 4.60 13 2.05E-12 5.13E-18 Absolute mass
4 0.38 5 4.24E-05 2.58E-10 Biomarker
9 7.30 6 3.02E-7 6.22E-13 Absolute mass
3 6.15 7 1.38E-5 3.47E-10 Absolute mass
counting
erved
s (Da)
Mass diff.
(ppm)
No. matching
fragments
Amino acid
labels E value
59.62 0.43 14 7K 4R 2.94E-19
59.62 0.42 8 7K 3R 1.87E-12
59.62 7.62 8 5K 5R 1.41E-12
59.62 9.80 7 2K 5R 8.23E-07
59.62 8.6015 6 0K 3R 4.21E-06
96.53 0.53 6 1R 3K 5.88E-09
96.53 8.74 4 1R 1K 5.94E-05
96.53 6.69 4 0R 1K 1.16e-06
96.53 5.99 4 2R 0K 3.30e-06
28.44 0.38 5 4K 2R 4.24E-05
28.44 6.33 4 3K 3R 6.71E-05
28.44 6.49 4 3K 3R 8.19E-05
28.44 6.33 4 4K 3R 1.26E-05
28.44 8.48 4 4K 1R 6.82E-05teom
erve
ass
Da)
77.7
60.4
96.5
70.4
64.0
59.6
33.5
35.7
28.4
37.2abel
Obs
mas
85
85
85
85
85
30
30
30
30
45
45
45
45
45
28.44 6.56 4 7K 0R 9.21E-05
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also in Figure 1. Varying differences in m/z between the
same y and b ion peaks arise from each fragment
containing a different number of labeled amino acids.
By comparing the difference in mass between those
peaks with the mass difference predicted by the as-
signed sequence of the protein, we can further increase
our confidence as to the identity of the protein analyte.
For instance, the y18
2 ion are expected to contain one
lysine and two arginines that should be heavier in the
labeled form of the protein by 20.054 Da. The m/z
difference of 10.027 in the experimental spectra (z  2)
Figure 2. The MS/MS spectra of light (black) an
overlaid to demonstrate the confirmation of fragm
in mass as correlated to the different numbers of labshown in Figure 1 corresponds closely to the predicted
mass difference. Likewise, the light and heavy forms of
the y58
5 ion have a predicted mass difference 64.15 Da
predicted by the assigned sequence, containing five
lysines and four arginines. The 12.83 m/z difference at
z 5 from the overlaid experimental spectra also match
with the predicted mass difference, and further confirm
the identification of the protein sequence.
Because the stable isotope labeled amino acids were
not 100% purely labeled, there exists an increasing
statistical probability that one or more light amino acids
will be incorporated as the number of amino acids to be
avy (blue) forms of ubiquitin c splice variant are
amino acid sequences based on their differencesd he
enteling amino acids incorporated.
886 COLLIER ET AL. J Am Soc Mass Spectrom 2010, 21, 879–889labeled in the protein increases. The result of such a
probability is an incomplete labeled intact protein,
being slightly lower in mass than the completely la-
beled counterpart. The abundance of these unlabeled
forms is modeled in eq 1, which takes into account the
number of amino acids to be labeled in the protein, N,
and the incorporation efficiency of the amino acid label,
E, and determines the relative abundance of the protein
signal arising from n unlabeled residues, An [29].
An
N!
n! (N n)!
En (1E)Nn (1)
To account for the use of both stable isotope labeled
arginine and lysine, in addition to the conversion of
heavy arginine to heavy proline, the abundance of the
completely labeled isotopic distribution is described by
eq 2:
AHA100%A100%1 NR!nR ! (NR nR)!ERnR
 (1ER)
NRnR1 NK!nK ! (NK nK)!EKnK
 (1EK)
NKnKNp%P100 (2)
Where AH the abundance of the completely labeled
protein, A100% is the abundance if labels were incorpo-
rated 100% of the time, NR is the number of arginine
residues in the protein, nR is the number of unlabeled
arginine residues in the protein, and ER is the incorpo-
ration efficiency of arginine. NK, nK, and EK represent
the same parameters for stable isotope labeled lysine,
and NP and %P are the number of prolines and percent
of conversion from arginine to proline, respectively.
To test the model described in eq 2 with the isotopic
distributions observed in the top-down analysis of
SILAC labeled hESCs, the amino acid incorporation
efficiency of both Arg6 and Lys8 were determined from
a parallel bottom-up proteomic analysis of just the
heavy-labeled cell lysate. Figure 3 shows results for
peptides corresponding to proteins identified in Figure
1, including the ubiquitin c splice variant (Figure 1a,
Figure 3a, b) and macrophage migration inhibitory
factor (Figure 1b, Figure 3c, d). Figure 3a shows the
mass spectrum of the peptide identified by MS/MS as
ESTLHLVLR from the ubiquitin c splice variant, includ-
ing the dominant signal from the form of the peptide
containing Arg6, and the much weaker signal from the
light form, amplified 50 times in the inset. Extracting
the ion chromatograms of the monoisotopic masses
from both the light and heavy forms and finding the
ratio of their peak areas suggests arginine incorporation
to be 98%. Similarly, Figure 3b shows the calculated
incorporation of Lys8, also 98%, from the mass spec-trum and extracted ion chromatogram of the peptide
TLSDYNIQK, which corresponds to the ubiquitin c
splice variant as well.
Peptides that correspond to macrophage migration
inhibitory factor are illustrated in Figure 3c and d. Both
were arginine terminated, and yielded Arg6 incorpo-
ration values of 98.5%. The contribution arginine-
proline conversion is visible in the mass spectrum of the
peptide identified as PMFIVNTNVPR (Figure 3c) as
indicated by the increased abundance of the fifth and
sixth isotopic peaks in the labeled peptide signal. The
area of the extracted ion chromatogram of the fifth
isotopic peak, which is actually the monoisotopic peak
of the heavy proline-containing form of the peptide,
compared with that of the heavy label, reveals roughly
5% conversion of arginine to proline.
Using the percent incorporation values of Arg6 and
Lys8 in addition to the percent conversion of Arg6 to
Pro5 obtained from bottom-up proteomic analysis, eqs 1
and 2 can be used in combination to plot the predicted
abundance of a completely SILAC labeled intact protein
signal (using eq 2) in addition to signals that arise from
having one or more unlabeled lysine or arginine residue
and furthermore the signal arising from the incorpora-
tion of Pro5 (using eq 1). Figure 4 shows the experimen-
tal mass spectra of two intact proteins overlaid upon the
inverted theoretical spectra as predicted by eqs 1 and 2.
The experimental spectrum of the 7 charge state of the
ubiquitin c splice variant is illustrated in Figure 4a,
where the predictive model accounts for 98% incorpo-
ration of Lys8 and Arg6 as determined by the peptide
level data discussed above and shown in Figure 3a, b.
Five percent conversion of arginine to proline is also
taken into account in the predicted spectra. All of the
theoretical predicted spectra are displayed on an in-
verted axis with the sum of the abundances of each
isotopic peak overlaid upon the experimental spec-
trum, showing a strong correlation between the two.
The theoretical isotopic distribution also strongly
correlates with the experimental spectrum for the
macrophage migration inhibitory factor SILAC pair
shown in Figure 3b.
Comparing the heavy isotopic distribution of Figure
4a to that of Figure 4b, the statistical relationships of the
model become more apparent. For instance, the maxi-
mum abundance of the heavy form of the ubiquitin c
splice variant is just over half that of the light form,
whereas the heavy form of the macrophage migration
inhibitory factor is 60% that of the light form. The
abundance of the SILAC labeled protein signal to its
unlabeled counterpart is related to the number of label-
ing amino acids present for which imperfect incorpora-
tion subtracts from the abundance of the completely
labeled form. This is evident in that the ubiquitin c
splice variant has 11 total arginine and lysine residues
for labeling versus eight residues for macrophage mi-
gration inhibitory factor. The greater number of label-
ing amino acids in ubiquitin increases the probability of
887J Am Soc Mass Spectrom 2010, 21, 879–889 TOP-DOWN PROTEOMICS OF hESCsone being unlabeled, leading to a more pronounced
“shoulder” of incompletely labeled protein in Figure 4a
compared with Figure 4b. Additionally, two proline
residues are present for potential incorporation of
heavy proline in ubiquitin c splice variant and eight
proline residues are present in macrophage migration
inhibitory factor, which in turn lead to a slightly more
pronounced “tail” from the heavy proline protein signal
Figure 3. MS spectra and extracted ion chrom
terminated peptides are used to calculate the p
(a) and (b) ubiquitin c splice variant, and (c) and
conversion is also demonstrated (c).in the latter relative to the former.Conclusions
Quantifying intact proteins using the SILAC method
remains a challenging task, even with the relatively
high incorporation of stable isotope labeled lysine and
arginine  98%. While the use of dual labeling strate-
gies is beneficial in the case of bottom-up quantification
by SILAC, even the small amount of light amino acid
ams of light and heavy of arginine and lysine
nt incorporation of each amino acid label into
acrophage migration inhibitory factor. Prolineatogr
erce
(d) mincorporated in the place of the stable isotope label is
iant a
888 COLLIER ET AL. J Am Soc Mass Spectrom 2010, 21, 879–889compounded. This effect is magnified further when a
labeling amino acid is converted by the biological
system into a different residue, as is the case with
arginine-proline conversion. Many of these effects can
be taken into account easily with quantification soft-
ware with bottom-up experiments, but remain unad-
dressed from the top-down perspective. Importantly,
multiple intact proteins were unambiguously identified,
including multiple intact forms of proteins for which only
a single form was identified from bottom-up analysis. It
would be beneficial in future studies involving intact
proteins for the use of a single, highly purified, essential
amino acid label to be utilized for SILAC labeling.
Stable isotope labeled lysine would be a strong candi-
date for future use, as it occurs frequently enough in the
proteome to be present in most proteins, is a limiting
amino acid, and is not converted biologically into other
amino acids. The result of this labeling system would be
less complex heavy protein isotope distributions for
easier intact protein quantification, giving researchers
the ability to thoroughly examine the intact proteomes
of human embryonic stem cells in addition other bio-
Figure 4. Experimental spectra are shown along
sum of model isotopic abundances of the inver
experimental spectra of (a) ubiquitin c splice varlogical systems.Acknowledgments
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